Related Experiment Video
Updated: May 17, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Chemosensitivity and p53; new tricks by an old dog
Breast Cancer Research : BCR
|November 8, 2012
Summary
Wild-type p53 protein can block doxorubicin
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The role of TP53 mutations in breast cancer chemosensitivity remains debated.
- Previous studies suggest varied responses to different chemotherapies based on TP53 status.
Purpose of the Study:
- To investigate the impact of wild-type p53 on doxorubicin treatment efficacy in breast cancer.
- To explore the mechanisms by which p53 influences chemotherapy response.
Main Methods:
- Utilized a mouse model to study the effects of doxorubicin treatment.
- Analyzed the role of wild-type p53 in inducing cellular senescence.
Main Results:
- Wild-type p53 protein was found to inhibit the anti-tumor effects of doxorubicin by inducing senescence.
- Senescence prevented mitotic catastrophe and subsequent cancer cell death.
- Contrasting findings exist regarding TP53 mutations and anthracycline resistance in human breast cancers.
Conclusions:
- The study presents a novel hypothesis regarding p53's role in doxorubicin resistance.
- Findings suggest new avenues for translational research in human breast cancer treatment.
- Further investigation is needed to reconcile conflicting data on TP53 mutations and chemotherapy response.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.